Comparison

LXE408 European Partner

Item no. TMO-T39214-10mg
Manufacturer TargetMol
CASRN 1799330-15-6
Amount 10 mg
Quantity options 10 mg 5 mg
Category
Type Inhibitors
Specific against other
Purity 0,98
Smiles Cc1nc(C)c(o1)C(=O)Nc1ccc(F)c(c1)-c1nc2ncc(cn2n1)-c1ncccc1C
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Shipping Condition Cool pack
Available
Shipping Temperature
cool pack
Storage Conditions
-20°
Molecular Weight
443, 442
Description
LXE408 is an orally active, kinetoplastid-selective proteasome inhibitor, exhibiting non-competitive inhibitory effects. It demonstrates an IC50 of 0.04 μM for L. donovani proteasome and an EC50 of 0.04 μM for L. donovani. Moreover, LXE408 shows limited ability to traverse the blood-brain barrier. Hence, LXE408 holds promise for advancing research in the field of visceral leishmaniasis (VL).

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 10 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close